Evidence map›Paper›PMID 22383946›Full record

SynthesisPloS one2012

Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.

Renaud Becquet, Milly Marston, François Dabis, Lawrence H Moulton, Glenda Gray, Hoosen M Coovadia, Max Essex, Didier K Ekouevi, Debra Jackson, Anna Coutsoudis and 9 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Impact of Point-of-Care Birth Test-and-Treat on Clinical Outcomes Among Infants With HIV: A Cluster-Randomized Trial in Mozambique and Tanzania.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. The time is now to use the tools we have to end AIDS in children.Journal of the International AIDS Society · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Viruses and Human Milk: Transmission or Protection?Advances in nutrition (Bethesda, Md.) · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 10 countries.

Renaud BecquetInstitut National de la Santé et de la Recherche Médicale, Unité 897, Centre de Recherche Epidémiologie et Biostatistique, Bordeaux, France. Renaud.Becquet@isped.u-bordeaux2.fr
Milly Marston
François Dabis
Lawrence H Moulton
Glenda Gray
Hoosen M Coovadia
Max Essex
Didier K Ekouevi
Debra Jackson
Anna Coutsoudis
Charles Kilewo
Valériane Leroy
Stefan Z Wiktor
Ruth Nduati
Philippe Msellati
Basia Zaba
Peter D Ghys
Marie-Louise Newell
UNAIDS Child Survival Group
Institut National de Recherche en Santé Publique · MLLondon School of Hygiene & Tropical Medicine · GBUniversity of KwaZulu-Natal · ZAUniversity of the Witwatersrand · ZAHarvard University Press · USJohns Hopkins University · USMuhimbili University of Health and Allied Sciences · TZProgramme PAC-CI · CIUnited Nations · USUniversité de Bordeaux · FRUniversity of Nairobi · KEUniversity of the Western Cape · ZAWest African Health Organisation · BF

Funding

Wellcome Trust 097410
6 · The paper itself

Abstract

backgroundAssumptions about survival of HIV-infected children in Africa without antiretroviral therapy need to be updated to inform ongoing UNAIDS modelling of paediatric HIV epidemics among children. Improved estimates of infant survival by timing of HIV-infection (perinatally or postnatally) are thus needed. METHODOLOGY/PRINCIPAL

findingsA pooled analysis was conducted of individual data of all available intervention cohorts and randomized trials on prevention of HIV mother-to-child transmission in Africa. Studies were right-censored at the time of infant antiretroviral initiation. Overall mortality rate per 1000 child-years of follow-up was calculated by selected maternal and infant characteristics. The Kaplan-Meier method was used to estimate survival curves by child's HIV infection status and timing of HIV infection. Individual data from 12 studies were pooled, with 12,112 children of HIV-infected women. Mortality rates per 1,000 child-years follow-up were 39.3 and 381.6 for HIV-uninfected and infected children respectively. One year after acquisition of HIV infection, an estimated 26% postnatally and 52% perinatally infected children would have died; and 4% uninfected children by age 1 year. Mortality was independently associated with maternal death (adjusted hazard ratio 2.2, 95%CI 1.6-3.0), maternal CD4<350 cells/ml (1.4, 1.1-1.7), postnatal (3.1, 2.1-4.1) or peri-partum HIV-infection (12.4, 10.1-15.3). CONCLUSIONS/

resultsThese results update previous work and inform future UNAIDS modelling by providing survival estimates for HIV-infected untreated African children by timing of infection. We highlight the urgent need for the prevention of peri-partum and postnatal transmission and timely assessment of HIV infection in infants to initiate antiretroviral care and support for HIV-infected children.

Indexed as

AdultAfrica South of the SaharaAnti-Retroviral AgentsBreast FeedingChild, PreschoolFemaleHIV-1HIV InfectionsHIV SeropositivityHumansInfantInfant MortalityInfant, NewbornInfectious Disease Transmission, VerticalMaleMilk, HumanAnti-Retroviral Agents

Identifiers

PMID22383946
PMCPMC3285615
OpenAlexW2136376685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.